JPY 1370.0
(0.88%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 14.65 Billion JPY | 9.91% |
2022 | 16.92 Billion JPY | 8.09% |
2021 | 15.05 Billion JPY | -10.04% |
2020 | 15.13 Billion JPY | 9.26% |
2019 | 20.31 Billion JPY | 7.27% |
2018 | 15.25 Billion JPY | -15.81% |
2017 | 17.34 Billion JPY | 20.39% |
2016 | 14.33 Billion JPY | -8.9% |
2015 | 15.7 Billion JPY | 42.02% |
2014 | 10.72 Billion JPY | 19.49% |
2013 | 9.18 Billion JPY | 22.52% |
2012 | 7.38 Billion JPY | -15.58% |
2011 | 9.04 Billion JPY | 19.01% |
2010 | 7.57 Billion JPY | 37.46% |
2009 | 5.51 Billion JPY | 43.02% |
2008 | 3.69 Billion JPY | -8.06% |
2007 | 3.97 Billion JPY | 36.23% |
2006 | 3.25 Billion JPY | -22.97% |
2005 | 3.73 Billion JPY | 9.28% |
2004 | 3.54 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 3.08 Billion JPY | 26.61% |
2024 Q1 | 1.86 Billion JPY | 92.64% |
2023 Q3 | 3.23 Billion JPY | 73.34% |
2023 Q1 | 1.66 Billion JPY | -10.37% |
2023 Q2 | 1.86 Billion JPY | 11.68% |
2023 FY | - JPY | 9.91% |
2023 Q4 | 5.19 Billion JPY | 60.91% |
2022 Q2 | 2.11 Billion JPY | 125.16% |
2022 Q1 | 938 Million JPY | 7.45% |
2022 FY | - JPY | 8.09% |
2022 Q4 | 1.86 Billion JPY | -38.99% |
2022 Q3 | 3.05 Billion JPY | 44.51% |
2021 Q1 | 942 Million JPY | -67.94% |
2021 FY | - JPY | -10.04% |
2021 Q2 | 1.61 Billion JPY | 71.02% |
2021 Q3 | 3.6 Billion JPY | 123.46% |
2021 Q4 | 873 Million JPY | -75.75% |
2020 Q3 | 3.18 Billion JPY | 32.32% |
2020 Q1 | 419 Million JPY | -79.56% |
2020 FY | - JPY | 9.26% |
2020 Q4 | 2.93 Billion JPY | -7.76% |
2020 Q2 | 2.4 Billion JPY | 474.46% |
2019 Q2 | 2.38 Billion JPY | 31.26% |
2019 FY | - JPY | 7.27% |
2019 Q1 | 1.81 Billion JPY | -27.82% |
2019 Q3 | 1.53 Billion JPY | -35.53% |
2019 Q4 | 2.05 Billion JPY | 33.55% |
2018 FY | - JPY | -15.81% |
2018 Q2 | 1.05 Billion JPY | 93.05% |
2018 Q3 | 2.7 Billion JPY | 156.34% |
2018 Q1 | 547 Million JPY | -76.65% |
2018 Q4 | 2.51 Billion JPY | -7.17% |
2017 Q3 | 3.5 Billion JPY | 29.54% |
2017 Q1 | 2.25 Billion JPY | -8.84% |
2017 Q2 | 2.7 Billion JPY | 19.88% |
2017 Q4 | 2.34 Billion JPY | -33.21% |
2017 FY | - JPY | 20.39% |
2016 Q1 | 1.66 Billion JPY | -48.29% |
2016 FY | - JPY | -8.9% |
2016 Q2 | 2.36 Billion JPY | 42.48% |
2016 Q4 | 2.47 Billion JPY | 13.0% |
2016 Q3 | 2.19 Billion JPY | -7.39% |
2015 Q3 | 3.15 Billion JPY | 46.56% |
2015 Q2 | 2.15 Billion JPY | 2.82% |
2015 Q4 | 3.21 Billion JPY | 1.9% |
2015 FY | - JPY | 42.02% |
2015 Q1 | 2.09 Billion JPY | -3.01% |
2014 Q4 | 2.15 Billion JPY | 8.55% |
2014 FY | - JPY | 19.49% |
2014 Q1 | 957 Million JPY | -18.76% |
2014 Q2 | 1.76 Billion JPY | 84.54% |
2014 Q3 | 1.98 Billion JPY | 12.57% |
2013 Q4 | 1.17 Billion JPY | -13.89% |
2013 FY | - JPY | 22.52% |
2013 Q1 | 1.11 Billion JPY | -23.77% |
2013 Q2 | 1.27 Billion JPY | 14.12% |
2013 Q3 | 1.36 Billion JPY | 7.13% |
2012 Q2 | 508 Million JPY | 58.75% |
2012 Q1 | 320 Million JPY | -74.86% |
2012 FY | - JPY | -15.58% |
2012 Q4 | 1.46 Billion JPY | 18.01% |
2012 Q3 | 1.24 Billion JPY | 144.88% |
2011 Q4 | 1.27 Billion JPY | 1.68% |
2011 Q3 | 1.25 Billion JPY | 2.71% |
2011 Q2 | 1.21 Billion JPY | -31.13% |
2011 FY | - JPY | 19.01% |
2011 Q1 | 1.77 Billion JPY | -34.77% |
2010 FY | - JPY | 37.46% |
2010 Q4 | 2.71 Billion JPY | 50.72% |
2010 Q3 | 1.8 Billion JPY | 3.83% |
2010 Q1 | 1.32 Billion JPY | -26.15% |
2010 Q2 | 1.73 Billion JPY | 30.58% |
2009 Q4 | 1.79 Billion JPY | 14.73% |
2009 Q2 | 1.13 Billion JPY | 11.48% |
2009 Q1 | 1.01 Billion JPY | -26.07% |
2009 FY | - JPY | 43.02% |
2009 Q3 | 1.56 Billion JPY | 38.5% |
2008 Q4 | 1.37 Billion JPY | 11.87% |
2008 Q2 | 645.84 Million JPY | 0.0% |
2008 FY | - JPY | -8.06% |
2008 Q3 | 1.22 Billion JPY | 90.02% |
2007 FY | - JPY | 36.23% |
2006 FY | - JPY | -22.97% |
2005 FY | - JPY | 9.28% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
HEARTSEED INC | -1.44 Billion JPY | 1111.9% |
Cawachi Limited | 11.85 Billion JPY | -23.65% |
Pharmarise Holdings Corporation | 2.08 Billion JPY | -602.541% |
Qol Holdings Co., Ltd. | 14.21 Billion JPY | -3.124% |
MatsukiyoCocokara & Co. | 98.01 Billion JPY | 85.049% |
Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 78.329% |
Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 39.81% |
COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 71.503% |
Tsuruha Holdings Inc. | 67.2 Billion JPY | 78.194% |
Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -284.041% |
Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -440.376% |
Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 52.172% |
Medical System Network Co., Ltd. | 6.99 Billion JPY | -109.477% |
Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -249.928% |
Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 71.12% |
YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -79.53% |
Astena Holdings Co., Ltd. | 4.17 Billion JPY | -251.251% |
Genky DrugStores Co., Ltd. | 14.47 Billion JPY | -1.251% |
Ain Holdings Inc. | 31.22 Billion JPY | 53.062% |
Sundrug Co.,Ltd. | 56.23 Billion JPY | 73.942% |